* NU Skin Enterprises Inc NUS.N NUS is expected to show a
fall in quarterly revenue when it reports results on November
3.
* The Provo, Utah-based company is expected to report a
9.0% decrease in revenue to $639.875 million from $703.35
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for NU Skin Enterprises Inc
is for earnings of 86 cents per share. For the same quarter last
year, the company reported earnings of $1.08 per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for NU Skin
Enterprises Inc is $51, about 20% above its last closing price
of $40.79.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Jun. 302021 1.06 1.05 1.15 Beat 10
Mar. 312021 0.73 0.72 0.91 Beat 26
Dec. 312020 1.18 1.19 1.40 Beat 17.9
Sep. 302020 1.03 0.98 1.08 Beat 10.7
Jun. 0.69 0.62 0.81 Beat 30.5
302020
Mar. 312020 0.25 0.25 0.36 Beat 42.6
Dec. 312019 0.72 0.72 0.72 Met 0.3
Sep. 302019 0.76 0.76 0.79 Beat 3.6
This summary was machine generated November 2 at 02:01 GMT. All
figures in US dollars unless otherwise stated